Cytokines in noninvasive diagnostics of diabetic nephropathy progression;Cytokiny w nieinwazyjnej diagnostyce nefropatii il cukrzycowej

Polski Merkuriusz Lekarski

Volumn 13, Issue SUPPL. 1, 2002, Pages 28-32

  Senatorski, Grzegorz ^a   Pa̧czek, Leszek ^a   Kropiewnicka, Eugenia ^a   Bartłomiejczyk, Irena ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Diabetic nephropathy; Mechanisms of progression of kidney diseases; Noninvasive diagnostic of kidney diseases; TGF 1 i IL 6

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MATRIX PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MORPHOLOGICAL TRAIT; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PROGNOSIS; RISK FACTOR; URINE LEVEL;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036444173     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Baranowska B.: Ogólne badanie moczu. W: Biochemia Kliniczna i Analityka (red. S. Angielski). Podrȩcznik dla. Med. Studium Zawod. Wydz. Analit. Med. PZWL. 1985, 723.
2. Bodor G.S. i wsp.: Standarization of glycohemoglobin determinations in the clinical laboratory. Three years of experince. Clin. Chem., 1992, 38, 2414.
3. 1. J. Immunol. Methods, 1993, 158, 17.
4. Fagerudd J.A. i wsp.: Urinary excretion of TGF-b1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int., 1997, 52, suppl. 63, S-195.
5. Gaines D.R.E., Poole S.: J. Immunol. Methods, 1992, 160, 147.
6. Goldstein G.S. i wsp.: Glycated hemoglobin: Methodologies and clinical applications. Clin. Chem., 1986, 32, B64.
7. Jałocha D.: Miejsce i rola lekarza rodzinnego w systemie opieki diabetologicznej. Nowa Medycyna, 1997, 12, 19.
8. Jasik M. i wsp.: Póżne powikłania cukrzycy - Zapobieganie i leczenie. Nowa Klinika, 1999, 6, 733.
9. Mauer S.M. i wsp.: Structural-functional relationships in diabetic nephropathy. J. Clin. Invest., 1984, 74, 1143.
10. Marks J. B., Raskin P.: Nephropathy and hypertension in diabetes. Med. Clin. North. Am., 1998, 82, 877.
11. Nakazato Y. i wsp.: Interleukin (IL)-1 and IL-4 sinergistically stimulate NF-IL6 activity and IL-6 production in human mesangial cells. Kidney Int., 1998, 54, 71.
12. Pa̧czek L. i wsp.: Systemic proteolytic enzyme treatment diminishes urinary interleukin 6 in diabetic patients. Nephron, 2000, 84, 194.
13. Pa̧czek L., Lao M.: Mechanizmy wioda̧ce do szkliwienia kłȩbków nerkowych. Pol. Tyg. Lek., 1993, 68, 442.
14. Pickup J.C. i wsp.: NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interlekin-6 with metabolic syndrome X. Diabetologia, 1997, 40, 1286.
15. Rossing P., Rossing K., Jacobsen P. i wsp.: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes, 1995, 44, 739.
16. 1 in patients with diabetic nephropathy. Am. J. Nephrol., 1998, 18, 490.
17. Sekizuka K. i wsp.: Detection of serum IL-6 in patients with diabetic nephropathy. Nephron, 1994, 68, 284.
18. Sternberg J.C.: A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin. Chem., 1977, 23, 1456.
19. Strojek K. i wsp.: Analiza zapadalności na cukrzycȩ w populacji dorosłych mieszkańców Zabrza. Czȩść 1. Cukrzyca insulinonieżalezna. Klinika, 1994, 3, 9.
20. Sunagawa H. i wsp.: Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron, 1996, 74, 361.
21. Suzuki D. i wsp.: In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes, 1995, 44, 1233.
22. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 1993, 329, 977-986.
23. Zeisberg M. i wsp.: Renal fibrosis: An update. Curr. Opin. Nephrol. Hypertens., 2001, 10, 315.
24. Ziyadeh F.N., Sharma K.: Extracellular matrix metabolism in diabetic nephropathy. Role of transforming growth factor-β in diabetic glomerutosclerosis and renal hypertrophy. Kidney Int., 1995, 48, suppl. 51, S-34.